Eli Lilly's CEO warns that bad policies may imperil pharmaceutical research. NEW YORK--Is the future of your health riding on what happens in Washington? Sidney Taurel thinks it might be. The Eli Lilly CEO ticks off a list of former "death sentences" being cured or turned into chronic conditions--"AIDS, leukemia, Hodgkin's, hopefully solid tumors within the next few years. The potential for medical research is unlimited. We just need to make sure we don't interdict it by the wrong policies." And what might those "wrong policies" be? Anything, it would appear, that reduces the financial incentives for drug companies to...